Because of the predominant role estrogens play in the development of breast cancer and the limited effectiveness of tamoxifen therapy, more selective therapeutics targeting estrogen signaling have been developed: selective estrogen receptor modulators (SERMs), selective estrogen receptor downregulators (SERDs), and a third generation of drugs that inhibit the aromatase required for estrogen biosyntheses. The authors examine clinical and translational research results from studies of these endocrine therapies and chemotherapies in pre- and postmenopausal women with early and advanced breast cancer. Advances in Endocrine Therapy of Breast Cancer provides guidance on promising new therapeutics and treatment combinations based on compelling clinical evidence.
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
Anbieter: -OnTimeBooks-, Phoenix, AZ, USA
Zustand: good. A copy that has been read, remains in good condition. All pages are intact, and the cover is intact. The spine and cover show signs of wear. Pages can include notes and highlighting and show signs of wear, and the copy can include "From the library of" labels or previous owner inscriptions. 100% GUARANTEE! Shipped with delivery confirmation, if you're not satisfied with purchase please return item! Ships via media mail. Bestandsnummer des Verkäufers OTV.0824722280.G
Anzahl: 1 verfügbar
Anbieter: Majestic Books, Hounslow, Vereinigtes Königreich
Zustand: New. pp. 350 This item is printed on demand. Bestandsnummer des Verkäufers 8350368
Anzahl: 1 verfügbar
Anbieter: Peak Pearl LLC, Holly Springs, NC, USA
Hardcover. Zustand: As New. 1st Edition. Like new, never been used. Bestandsnummer des Verkäufers D9780824722289
Anzahl: 1 verfügbar
Anbieter: Rob the Book Man, Vancouver, WA, USA
Hardcover. Zustand: Fine. hardback in fine condition. Bestandsnummer des Verkäufers 20236
Anzahl: 1 verfügbar
Anbieter: SHIMEDIA, Brooklyn, NY, USA
Zustand: New. Satisfaction Guaranteed or your money back. Bestandsnummer des Verkäufers 0824722280